Facebook
Twitter
Telegram
Report an ErrorDiffusion Pharmaceuticals Cash Flow 2011-2024 | DFFN
Annual Cash Flow Diffusion Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-7.45 M | -2.57 M | -14.5 M | -13.6 M | -9.86 M | -10.8 M | -12.3 M | -10.8 M | -5.19 M | -9.03 M | -1.18 M | -4.31 M | -12 M |
Depreciation & Amortization |
- | - | 93.4 K | 103 K | 97.9 K | 110 K | 68 K | 25.3 K | 23.3 K | 566 K | 116 K | 164 K | 69.8 K |
Accounts Payables |
662 K | 97.3 K | 947 K | 546 K | 1.25 M | 199 K | 512 K | 1.68 M | 36.1 K | 417 K | 1.52 M | 1.2 M | 789 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Diffusion Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.42 M | - | - | - | -1.48 M | - | -11.5 M | -8.74 M | -4.73 M | - | -11.5 M | -8.5 M | -5.18 M | - | -10.2 M | -6.65 M | -3.5 M | - | -7.42 M | -5.27 M | -2.66 M | - | -7.75 M | -5.83 M | -3.29 M | - | -10.1 M | -6.16 M | -3.42 M | - | -9.35 M | -7.49 M | -4.63 M | - | -2.92 M | -1.94 M | -939 K | - | -7.1 M | -5.12 M | -433 K | - | -1.18 M | -851 K | -401 K | - | -2.81 M | -2.25 M | -1.85 M | - | -8.8 M | -4.35 M | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | 67.3 K | 48.2 K | 24.4 K | - | 78.2 K | 54 K | 27 K | - | 70.8 K | 52.7 K | 18.3 K | - | 81.4 K | 54.7 K | 28 K | - | 39.8 K | 12.4 K | 6.6 K | - | 19.5 K | - | - | - | 5.39 K | 6.2 K | 6.28 K | - | 369 K | 324 K | 191 K | - | 7.48 K | 7.48 K | 8.69 K | - | 9.86 K | 9.86 K | 9.88 K | - | 21.8 K | 13.4 K | - |
Accounts Payables |
680 K | 662 K | 534 K | 932 K | 971 K | 97.3 K | 807 K | 846 K | 813 K | 947 K | 678 K | 750 K | 953 K | 546 K | 546 K | 546 K | 546 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 199 K | 199 K | 199 K | 199 K | 512 K | 512 K | 512 K | 512 K | 1.68 M | 1.68 M | 1.68 M | 1.68 M | 425 K | 425 K | 425 K | 425 K | 417 K | 417 K | 417 K | 417 K | 1.52 M | 1.52 M | 1.52 M | 1.52 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 789 K | 789 K | 789 K | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.7 K | - | - | 58.5 K | 53.5 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency